DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-804 Cr |
Mar2024 | ₹-269 Cr |
Mar2023 | ₹-2,707 Cr |
Mar2022 | ₹-2,195 Cr |
Mar2021 | ₹75 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-804 Cr | Negative | |
Mar2024 | ₹-269 Cr | Negative | |
Mar2023 | ₹-2,707 Cr | Negative | |
Mar2022 | ₹-2,195 Cr | Negative | |
Mar2021 | ₹75 Cr | - |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹168,831.5 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,753.0 Cr | 0.8% | 8.4% | 26.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -3.3% |
-7.4% |
34.1% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses